Skip to main content
SpringerLink
Log in

Secondary Forms of Hypertension

  • Chapter
  • First Online:
Pediatric Hypertension

Part of the book series: Clinical Hypertension and Vascular Diseases ((CHVD))

Abstract

In most studies, hypertension in children has been secondary to an identifiable cause in a large majority of those studied (1,2). This has changed during the relatively recent epidemic of childhood obesity, where primary hypertension in many centers now is the most common cause form of hypertension (3). In adults primary hypertension is the dominating diagnosis. This chapter will discuss those cases where a cause for the hypertension has been possible to identify. It is quite possible that in the future some children that presently are diagnosed with primary or essential hypertension will be found to have an underlying diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Similar content being viewed by others

References

  1. Gill DG, Mendes de CB, Cameron JS, Joseph MC, Ogg CS, Chantler C. Analysis of 100 children with severe and persistent hypertension. Arch Dis Child. Dec 1976;51(12):951–956.

    Article  PubMed  CAS  Google Scholar 

  2. Wyszynska T, Cichocka E, Wieteska-Klimczak A, Jobs K, Januszewicz P. A single pediatric center experience with 1025 children with hypertension. Acta Paediatr. Mar 1992;81(3):244–246.

    Article  PubMed  CAS  Google Scholar 

  3. Sorof J, Daniels S. Obesity hypertension in children: a problem of epidemic proportions. Hypertension. Oct 2002;40(4):441–447.

    Article  PubMed  CAS  Google Scholar 

  4. Bissler JJ, Welch TR, Loggie JM. Paradoxical hypertension in hypovolemic children. Pediatr Emerg Care. Dec 1991;7(6):350–352.

    Article  PubMed  CAS  Google Scholar 

  5. Cooper WO, Daniels SR, Loggie JM. Prevalence and correlates of blood pressure elevation in children with Guillain-Barre syndrome. Clin Pediatr (Phila). Oct 1998;37(10):621–624.

    Article  CAS  Google Scholar 

  6. Perlstein MA, Ndelman MB, Rosner DC, Wehrle P. Incidence of hypertension in poliomyelitis. Pediatrics. June 1953;11(6):628–633.

    PubMed  CAS  Google Scholar 

  7. Ferdinand KC. Substance abuse and hypertension. J Clin Hypertens (Greenwich). Jan 2000;2(1):37–40.

    Google Scholar 

  8. Flynn JT. Neonatal hypertension: diagnosis and management. Pediatr Nephrol. Apr 2000;14(4):332–341.

    Article  PubMed  CAS  Google Scholar 

  9. Flynn JT, Mitsnefes M, Pierce C, et al. Blood pressure in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children study. Hypertension. Oct 2008;52(4):631–637.

    Article  PubMed  CAS  Google Scholar 

  10. Martinez-Maldonado M. Hypertension in end-stage renal disease. Kidney Int Suppl. Dec 1998;68:S67–S72.

    Article  PubMed  CAS  Google Scholar 

  11. Wennerstrom M, Hansson S, Hedner T, Himmelmann A, Jodal U. Ambulatory blood pressure 16-26 years after the first urinary tract infection in childhood. J Hypertens. Apr 2000;18(4):485–491.

    Article  PubMed  CAS  Google Scholar 

  12. Goonasekera CD, Shah V, Wade AM, Barratt TM, Dillon MJ. 15-Year follow-up of renin and blood pressure in reflux nephropathy. Lancet. Mar 1996 9;347(9002):640–643.

    Article  PubMed  CAS  Google Scholar 

  13. Patzer L, Seeman T, Luck C, Wuhl E, Janda J, Misselwitz J. Day- and night-time blood pressure elevation in children with higher grades of renal scarring. J Pediatr. Feb 2003;142(2):117–122.

    Article  PubMed  Google Scholar 

  14. Avner ED. Childhood ADPKD: answers and more questions. Kidney Int. May 2001;59(5):1979–1980.

    Article  PubMed  CAS  Google Scholar 

  15. Sedman A, Bell P, Manco-Johnson M, et al. Autosomal dominant polycystic kidney disease in childhood: a longitudinal study. Kidney Int. Apr 1987;31(4):1000–1005.

    Article  PubMed  CAS  Google Scholar 

  16. Chapman AB, Schrier RW. Pathogenesis of hypertension in autosomal dominant polycystic kidney disease. Semin Nephrol. Nov 1991;11(6):653–660.

    PubMed  CAS  Google Scholar 

  17. Davis ID, MacRae DK, Sweeney WE, Avner ED. Can progression of autosomal dominant or autosomal recessive polycystic kidney disease be prevented? Semin Nephrol. Sept 2001;21(5):430–440.

    Article  PubMed  CAS  Google Scholar 

  18. Taylor CM. Hemolytic-uremic syndrome and complement factor H deficiency: clinical aspects. Semin Thromb Hemost. June 2001;27(3):185–190.

    Article  PubMed  CAS  Google Scholar 

  19. Krmar RT, Ferraris JR, Ramirez JA, et al. Ambulatory blood pressure monitoring after recovery from hemolytic uremic syndrome. Pediatr Nephrol. Oct 2001;16(10):812–816.

    Article  PubMed  CAS  Google Scholar 

  20. Tullus K, Brennan E, Hamilton G, et al. Renovascular hypertension in children. Lancet. Apr 2008;371(9622):1453–1463.

    Article  PubMed  CAS  Google Scholar 

  21. Vo NJ, Hammelman BD, Racadio JM, Strife CF, Johnson ND, Racadio JM. Anatomic distribution of renal artery stenosis in children: implications for imaging. Pediatr Radiol. Oct 2006;36(10):1032–1036.

    Article  PubMed  Google Scholar 

  22. Daniels SR, Loggie JM, McEnery PT, Towbin RB. Clinical spectrum of intrinsic renovascular hypertension in children. Pediatrics. Nov 1987;80(5):698–704.

    PubMed  CAS  Google Scholar 

  23. Deal JE, Snell MF, Barratt TM, Dillon MJ. Renovascular disease in childhood. J Pediatr. Sept 1992;121(3):378–384.

    Article  PubMed  CAS  Google Scholar 

  24. Panayiotopoulos YP, Tyrrell MR, Koffman G, Reidy JF, Haycock GB, Taylor PR. Mid-aortic syndrome presenting in childhood. Br J Surg. Feb 1996;83(2):235–240.

    Article  PubMed  CAS  Google Scholar 

  25. Sethna CB, Kaplan BS, Cahill AM, Velazquez OC, Meyers KE. Idiopathic mid-aortic syndrome in children. Pediatr Nephrol. Jul 2008;23(7):1135–1142.

    Article  PubMed  Google Scholar 

  26. Sandmann W, Schulte KM. Multivisceral fibromuscular dysplasia in childhood: case report and review of the literature. Ann Vasc Surg. Sept 2000;14(5):496–502.

    Article  PubMed  CAS  Google Scholar 

  27. Slovut DP, Olin JW. Fibromuscular dysplasia. N Engl J Med. Apr 2004 ;350(18):1862–1871.

    Article  PubMed  CAS  Google Scholar 

  28. Criado E, Izquierdo L, Lujan S, Puras E, del Mar EM. Abdominal aortic coarctation, renovascular, hypertension, and neurofibromatosis. Ann Vasc Surg. May 2002;16(3):363–367.

    Article  PubMed  Google Scholar 

  29. Kurien A, John PR, Milford DV. Hypertension secondary to progressive vascular neurofibromatosis. Arch Dis Child. May 1997;76(5):454–455.

    Article  PubMed  CAS  Google Scholar 

  30. Daniels SR, Loggie JM, Schwartz DC, Strife JL, Kaplan S. Systemic hypertension secondary to peripheral vascular anomalies in patients with Williams syndrome. J Pediatr. Feb 1985;106(2):249–251.

    Article  PubMed  CAS  Google Scholar 

  31. Hari P, Bagga A, Srivastava RN. Sustained hypertension in children. Indian Pediatr. Mar 2000;37(3):268–274.

    PubMed  CAS  Google Scholar 

  32. McCulloch M, Andronikou S, Goddard E, et al. Angiographic features of 26 children with Takayasu’s arteritis. Pediatr Radiol. Apr 2003;33(4):230–235.

    PubMed  Google Scholar 

  33. Estepa R, Gallego N, Orte L, Puras E, Aracil E, Ortuno J. Renovascular hypertension in children. Scand J Urol Nephrol. Oct 2001;35(5):388–392.

    Article  PubMed  CAS  Google Scholar 

  34. McTaggart SJ, Gulati S, Walker RG, Powell HR, Jones CL. Evaluation and long-term outcome of pediatric renovascular hypertension. Pediatr Nephrol. Sept 2000;14(10–11):1022–1029.

    Article  PubMed  CAS  Google Scholar 

  35. Shroff R, Roebuck DJ, Gordon I, et al. Angioplasty for renovascular hypertension in children: 20-year experience. Pediatrics. Jul 2006;118(1):268–275.

    Article  PubMed  Google Scholar 

  36. Shahdadpuri J, Frank R, Gauthier BG, Siegel DN, Trachtman H. Yield of renal arteriography in the evaluation of pediatric hypertension. Pediatr Nephrol. Aug 2000;14(8–9):816–819.

    Article  PubMed  CAS  Google Scholar 

  37. Brun P, Kchouk H, Mouchet B, et al. Value of Doppler ultrasound for the diagnosis of renal artery stenosis in children. Pediatr Nephrol. Feb 1997;11(1):27–30.

    Article  PubMed  CAS  Google Scholar 

  38. Eklof H, Ahlstrom H, Magnusson A, et al. A prospective comparison of duplex ultrasonography, captopril renography, MRA, and CTA in assessing renal artery stenosis. Acta Radiol. Oct 2006;47(8):764–774.

    Article  PubMed  CAS  Google Scholar 

  39. Garel L, Dubois J, Robitaille P, et al. Renovascular hypertension in children: curability predicted with negative intrarenal Doppler US results. Radiology. May 1995;195(2):401–405.

    PubMed  CAS  Google Scholar 

  40. Li JC, Wang L, Jiang YX, et al. Evaluation of renal artery stenosis with velocity parameters of Doppler sonography. J Ultrasound Med. Jun 2006;25(6):735–742.

    PubMed  Google Scholar 

  41. Dondi M. Captopril renal scintigraphy with 99mTc-mercaptoacetyltriglycine (99mTc-MAG3) for detecting renal artery stenosis. Am J Hypertens. Dec 1991;4(12 Pt 2):737S–740S.

    PubMed  CAS  Google Scholar 

  42. Arora P, Kher V, Singhal MK, et al. Renal artery stenosis in aortoarteritis: spectrum of disease in children and adults. Kidney Blood Press Res. 1997;20(5):285–289.

    Article  PubMed  CAS  Google Scholar 

  43. Fommei E, Ghione S, Hilson AJ, et al. Captopril radionuclide test in renovascular hypertension: a European multicentre study. European Multicentre Study Group. Eur J Nucl Med. Jul 1993;20(7):617–623.

    Article  PubMed  CAS  Google Scholar 

  44. Minty I, Lythgoe MF, Gordon I. Hypertension in paediatrics: can pre- and post-captopril technetium-99m dimercaptosuccinic acid renal scans exclude renovascular disease? Eur J Nucl Med. Aug 1993;20(8):699–702.

    Article  PubMed  CAS  Google Scholar 

  45. Ng CS, de Bruyn R, Gordon I. The investigation of renovascular hypertension in children: the accuracy of radio-isotopes in detecting renovascular disease. Nucl Med Commun. Nov 1997;18(11):1017–1028.

    Article  PubMed  CAS  Google Scholar 

  46. Abdulsamea S, Anderson P, Biassoni L, Brennan E, McLaren CA, Marks SD, Roebuck DJ, Selim S, Tullus K. Pre- and post-captopril renal scintigraphy as a screening test for renovascular hypertension in children. Pediatr Nephrol. 2010;25:317–322.

    Google Scholar 

  47. Hacklander T, Mertens H, Stattaus J, et al. Evaluation of renovascular hypertension: comparison of functional MRI and contrast-enhanced MRA with a routinely performed renal scintigraphy and DSA. J Comput Assist Tomogr. Nov 2004;28(6):823–831.

    Article  PubMed  Google Scholar 

  48. Vasbinder GB, Nelemans PJ, Kessels AG, et al. Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Ann Intern Med. Nov 2004;141(9):674–682.

    PubMed  Google Scholar 

  49. Miller JM, Rochitte CE, Dewey M, et al. Diagnostic performance of coronary angiography by 64-row CT. N Engl J Med. Nov 2008;359(22):2324–2336.

    Article  PubMed  CAS  Google Scholar 

  50. Dillon MJ, Ryness JM. Plasma renin activity and aldosterone concentration in children. Br Med J. Nov 1975;4(5992):316–319.

    Article  PubMed  CAS  Google Scholar 

  51. Goonasekera CD, Shah V, Wade AM, Dillon MJ. The usefulness of renal vein renin studies in hypertensive children: a 25-year experience. Pediatr Nephrol. Nov 2002;17(11):943–949.

    Article  PubMed  Google Scholar 

  52. Teigen CL, Mitchell SE, Venbrux AC, Christenson MJ, McLean RH. Segmental renal artery embolization for treatment of pediatric renovascular hypertension. J Vasc Interv Radiol. Feb 1992;3(1):111–117.

    Article  PubMed  CAS  Google Scholar 

  53. Wong H, Hadi M, Khoury T, Geary D, Rubin B, Filler G. Management of severe hypertension in a child with tuberous sclerosis-related major vascular abnormalities. J Hypertens. Mar 2006;24(3):597–599.

    Article  PubMed  CAS  Google Scholar 

  54. Konig K, Gellermann J, Querfeld U, Schneider MB. Treatment of severe renal artery stenosis by percutaneous transluminal renal angioplasty and stent implantation: review of the pediatric experience: apropos of two cases. Pediatr Nephrol. May 2006;21(5):663–671.

    Article  PubMed  Google Scholar 

  55. McLaren CA, Roebuck DJ. Interventional radiology for renovascular hypertension in children. Tech Vasc Interv Radiol. Dec 2003;6(4):150–157.

    Article  PubMed  Google Scholar 

  56. Imamura H, Isobe M, Takenaka H, Kinoshita O, Sekiguchi M, Ohta M. Successful stenting of bilateral renal artery stenosis due to fibromuscular dysplasia assessed by use of pressure guidewire technique: a case report. Angiology. Jan 1998;49(1):69–74.

    Article  PubMed  CAS  Google Scholar 

  57. Ing FF, Goldberg B, Siegel DH, Trachtman H, Bierman FZ. Arterial stents in the management of neurofibromatosis and renovascular hypertension in a pediatric patient: case report of a new treatment modality. Cardiovasc Intervent Radiol. Nov 1995;18(6):414–418.

    Article  PubMed  CAS  Google Scholar 

  58. Liang CD, Wu CJ, Fang CY, Ko SF. Endovascular stent placement for management of total renal artery occlusion in a child. J Invasive Cardiol. Jan 2002;14(1):32–35.

    PubMed  Google Scholar 

  59. Lange RA, Hillis LD. Coronary revascularization in context. N Engl J Med. Mar 2009;360(10):1024–1026.

    Article  PubMed  CAS  Google Scholar 

  60. Ishijima H, Ishizaka H, Sakurai M, Ito K, Endo K. Partial renal embolization for pediatric renovascular hypertension secondary to fibromuscular dysplasia. Cardiovasc Intervent Radiol. Sept 1997;20(5):383–386.

    Article  PubMed  CAS  Google Scholar 

  61. Hegde S, Coulthard MG. Follow-up of early unilateral nephrectomy for hypertension. Arch Dis Child Fetal Neonatal Ed. Jul 2007;92(4):F305–F306.

    Article  PubMed  Google Scholar 

  62. Stanley JC, Criado E, Upchurch GR Jr, et al. Pediatric renovascular hypertension: 132 primary and 30 secondary operations in 97 children. J Vasc Surg. Dec 2006;44(6):1219–1228.

    Article  PubMed  Google Scholar 

  63. O’Neill JA Jr, Berkowitz H, Fellows KJ, Harmon CM. Midaortic syndrome and hypertension in childhood. J Pediatr Surg. Feb 1995;30(2):164–171.

    Article  PubMed  Google Scholar 

  64. Stanley JC, Zelenock GB, Messina LM, Wakefield TW. Pediatric renovascular hypertension: a thirty-year experience of operative treatment. J Vasc Surg. Feb 1995;21(2):212–226.

    Article  PubMed  CAS  Google Scholar 

  65. Staderman MB, Montinin G, Hamilton G, Roebuck DJ, McLaren CA, Dillon MJ, Marks SD, Tullus K. Nephrology Dialysis Transplantation. 2010;25:807–813.

    Google Scholar 

  66. Haab F, Duclos JM, Guyenne T, Plouin PF, Corvol P. Renin secreting tumors: diagnosis, conservative surgical approach and long-term results. J Urol. Jun 1995;153(6):1781–1784.

    Article  PubMed  CAS  Google Scholar 

  67. Steinbrecher HA, Malone PS. Wilms’ tumour and hypertension: incidence and outcome. Br J Urol. Aug 1995;76(2):241–243.

    Article  PubMed  CAS  Google Scholar 

  68. Warshaw BL, Anand SK, Olson DL, Grushkin CM, Heuser ET, Lieberman E. Hypertension secondary to a renin-producing juxtaglomerular cell tumor. J Pediatr. Feb 1979;94(2):247–250.

    Article  PubMed  CAS  Google Scholar 

  69. McCrindle BW. Coarctation of the aorta. Curr Opin Cardiol. Sept 1999;14(5):448–452.

    Article  PubMed  CAS  Google Scholar 

  70. Walhout RJ, Plokker HW, Meijboom EJ, Doevendans PA. Advances in the management and surveillance of patients with aortic coarctation. Acta Cardiol. Dec 2008;63(6):771–782.

    Article  PubMed  Google Scholar 

  71. Bagby SP. Acute responses to arterial pressure and plasma renin activity to converting enzyme inhibition (SQ 20,881) in serially studied dogs with neonatally-induced coarctation hypertension. Hypertension. Jan 1982;4(1):146–154.

    PubMed  CAS  Google Scholar 

  72. Roegel JC, Heinrich E, De JW, et al. Vascular and neuroendocrine components in altered blood pressure regulation after surgical repair of coarctation of the aorta. J Hum Hypertens. Aug 1998;12(8):517–525.

    Article  PubMed  CAS  Google Scholar 

  73. Yagi S, Kramsch DM, Madoff IM, Hollander W. Plasma renin activity in hypertension associated with coarctation of the aorta. Am J Physiol. Sept 1968;215(3):605–610.

    PubMed  CAS  Google Scholar 

  74. Hamilton JR. Surgical controversies: coarctation. Cardiol Young. Jan 1998;8(1):50–53.

    Article  PubMed  CAS  Google Scholar 

  75. Wong D, Benson LN, Van Arsdell GS, Karamlou T, McCrindle BW. Balloon angioplasty is preferred to surgery for aortic coarctation. Cardiol Young. Feb 2008;18(1):79–88.

    Article  PubMed  Google Scholar 

  76. Seirafi PA, Warner KG, Geggel RL, Payne DD, Cleveland RJ. Repair of coarctation of the aorta during infancy minimizes the risk of late hypertension. Ann Thorac Surg. Oct 1998;66(4):1378–1382.

    Article  PubMed  CAS  Google Scholar 

  77. Abman SH. Monitoring cardiovascular function in infants with chronic lung disease of prematurity. Arch Dis Child Fetal Neonatal Ed. Jul 2002;87(1):F15–F18.

    Article  PubMed  CAS  Google Scholar 

  78. Emery EF, Greenough A. Neonatal blood pressure levels of preterm infants who did and did not develop chronic lung disease. Early Hum Dev. Dec 1992;31(2):149–156.

    Article  PubMed  CAS  Google Scholar 

  79. Armstrong R, Sridhar M, Greenhalgh KL, et al. Phaeochromocytoma in children. Arch Dis Child. Oct 2008;93(10):899–904.

    Article  PubMed  CAS  Google Scholar 

  80. Havekes B, Romijn JA, Eisenhofer G, Adams K, Pacak K. Update on pediatric pheochromocytoma. Pediatr Nephrol. May 2009;24(5):943–950.

    Article  PubMed  Google Scholar 

  81. Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet. Aug 2005;366(9486):665–675.

    Article  PubMed  Google Scholar 

  82. Pacak K, Eisenhofer G, Ahlman H, et al. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nat Clin Pract Endocrinol Metab. Feb 2007;3(2):92–102.

    Article  PubMed  Google Scholar 

  83. de Krijger RR, Petri BJ, van Nederveen FH, et al. Frequent genetic changes in childhood pheochromocytomas. Ann N Y Acad Sci. Aug 2006;1073:166–176.

    Article  PubMed  CAS  Google Scholar 

  84. Tischler AS, Kimura N, McNicol AM. Pathology of pheochromocytoma and extra-adrenal paraganglioma. Ann N Y Acad Sci. Aug 2006;1073:557–570.

    Article  PubMed  Google Scholar 

  85. Neumann HP, Pawlu C, Peczkowska M, et al. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA. Aug 25 2004;292(8):943–951.

    Article  PubMed  CAS  Google Scholar 

  86. Barontini M, Levin G, Sanso G. Characteristics of pheochromocytoma in a 4- to 20-year-old population. Ann N Y Acad Sci. Aug 2006;1073:30–37.

    Article  PubMed  Google Scholar 

  87. Pham TH, Moir C, Thompson GB, et al. Pheochromocytoma and paraganglioma in children: a review of medical and surgical management at a tertiary care center. Pediatrics. Sept 2006;118(3):1109–1117.

    Article  PubMed  Google Scholar 

  88. Ludwig AD, Feig DI, Brandt ML, Hicks MJ, Fitch ME, Cass DL. Recent advances in the diagnosis and treatment of pheochromocytoma in children. Am J Surg. Dec 2007;194(6):792–796.

    Article  PubMed  CAS  Google Scholar 

  89. Sawka AM, Jaeschke R, Singh RJ, Young WF Jr. A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab. Feb 2003;88(2):553–558.

    Article  PubMed  CAS  Google Scholar 

  90. Weise M, Merke DP, Pacak K, Walther MM, Eisenhofer G. Utility of plasma free metanephrines for detecting childhood pheochromocytoma. J Clin Endocrinol Metab. May 2002;87(5):1955–1960.

    Article  PubMed  CAS  Google Scholar 

  91. Bockenhauer D, Rees L, Neumann H, Foo Y. A sporadic case of paraganglioma undetected by urine metabolite screening. Pediatr Nephrol. Oct 2008;23(10):1889–1891.

    Article  PubMed  Google Scholar 

  92. Erickson D, Kudva YC, Ebersold MJ, et al. Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab. 2001;86(11):5210–5216.

    Article  PubMed  CAS  Google Scholar 

  93. Nielsen JT, Nielsen BV, Rehling M. Location of adrenal medullary pheochromocytoma by I-123 metaiodobenzylguanidine SPECT. Clin Nucl Med. Sept 1996;21(9):695–699.

    Article  PubMed  CAS  Google Scholar 

  94. van der HE, de Herder WW, Bruining HA, et al. [(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in benign and malignant pheochromocytomas. J Clin Endocrinol Metab. Feb 2001;86(2):685–693.

    Article  Google Scholar 

  95. Goldstein RE, O’Neill JA Jr, Holcomb GW III, et al. Clinical experience over 48 years with pheochromocytoma. Ann Surg. Jun 1999;229(6):755–764.

    Article  PubMed  CAS  Google Scholar 

  96. Hack HA. The perioperative management of children with phaeochromocytoma. Paediatr Anaesth. 2000;10(5):463–476.

    Article  PubMed  CAS  Google Scholar 

  97. Pacak K. Preoperative management of the pheochromocytoma patient. J Clin Endocrinol Metab. Nov 2007;92(11):4069–4079.

    Article  PubMed  CAS  Google Scholar 

  98. Brunt LM, Lairmore TC, Doherty GM, Quasebarth MA, DeBenedetti M, Moley JF. Adrenalectomy for familial pheochromocytoma in the laparoscopic era. Ann Surg. May 2002;235(5):713–720.

    Article  PubMed  Google Scholar 

  99. Kravarusic D, Pinto-Rojas A, Al-Assiri A, Sigalet D. Laparoscopic resection of extra-adrenal pheochromocytoma—case report and review of the literature in pediatric patients. J Pediatr Surg. Oct 2007;42(10):1780–1784.

    Article  PubMed  Google Scholar 

  100. Nieman LK, Ilias I. Evaluation and treatment of Cushing’s syndrome. Am J Med. Dec 2005;118(12):1340–1346.

    Article  PubMed  Google Scholar 

  101. Savage MO, Chan LF, Grossman AB, Storr HL. Work-up and management of paediatric Cushing’s syndrome. Curr Opin Endocrinol Diabetes Obes. Aug 2008;15(4):346–351.

    Article  PubMed  Google Scholar 

  102. Peters CJ, Ahmed ML, Storr HL, et al. Factors influencing skeletal maturation at diagnosis of paediatric Cushing’s disease. Horm Res. 2007;68(5):231–235.

    Article  PubMed  CAS  Google Scholar 

  103. Kirk JM, Brain CE, Carson DJ, Hyde JC, Grant DB. Cushing’s syndrome caused by nodular adrenal hyperplasia in children with McCune-Albright syndrome. J Pediatr. Jun 1999;134(6):789–792.

    Article  PubMed  CAS  Google Scholar 

  104. Batista DL, Riar J, Keil M, Stratakis CA. Diagnostic tests for children who are referred for the investigation of Cushing syndrome. Pediatrics. Sept 2007;120(3):e575–e586.

    Article  PubMed  Google Scholar 

  105. Joshi SM, Hewitt RJ, Storr HL, et al. Cushing’s disease in children and adolescents: 20 years of experience in a single neurosurgical center. Neurosurgery. Aug 2005;57(2):281–285.

    Article  PubMed  Google Scholar 

  106. Abasiyanik A, Oran B, Kaymakci A, Yasar C, Caliskan U, Erkul I. Conn syndrome in a child, caused by adrenal adenoma. J Pediatr Surg. Mar 1996;31(3):430–432.

    Article  PubMed  CAS  Google Scholar 

  107. Ferrari P, Bianchetti M, Frey FJ. Juvenile hypertension, the role of genetically altered steroid metabolism. Horm Res. 2001;55(5):213–223.

    Article  PubMed  CAS  Google Scholar 

  108. Migeon CJ. Over 50 years of progress in the treatment of the hypertensive form of congenital adrenal hyperplasia due to steroid 11-beta-hydroxylase deficiency. Commentary on Simm PJ and Zacharin MR: successful pregnancy in a patient with severe 11-beta-hydroxylase deficiency and novel mutations in CYP11B1 gene (Horm Res. 2007;68:294–297). Horm Res. 2007;68(6):298–299.

    Article  PubMed  CAS  Google Scholar 

  109. Biglieri EG, Kater CE. 17 Alpha-hydroxylation deficiency. Endocrinol Metab Clin North Am. Jun 1991;20(2):257–268.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nephrology, Great Ormond Street Hospital for Children, London, UK

    Kjell Tullus MD, PhD, FRCPCH

Authors
  1. Kjell Tullus MD, PhD, FRCPCH
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kjell Tullus MD, PhD, FRCPCH .

Editor information

Editors and Affiliations

  1. , Division of Nephrology, Seattle Children's Hospital, Sand Point Way NE. 4800, Seattle, 98105, Washington, USA

    Joseph T. Flynn

  2. Massachusetts General Hospital, Fruit St. 55, Boston, 02114, Massachusetts, USA

    Julie R. Ingelfinger

  3. Global Clinical Research, Bristol-Myers Squibb, Route 206 & Provinceline Road, Princeton, 08543, New Jersey, USA

    Ronald J. Portman

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Tullus, K. (2011). Secondary Forms of Hypertension. In: Flynn, J., Ingelfinger, J., Portman, R. (eds) Pediatric Hypertension. Clinical Hypertension and Vascular Diseases. Humana Press. https://doi.org/10.1007/978-1-60327-824-9_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-824-9_20

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60327-823-2

  • Online ISBN: 978-1-60327-824-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation